Search

Your search keyword '"Zagonel V"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Zagonel V" Remove constraint Author: "Zagonel V" Topic medicine Remove constraint Topic: medicine
50 results on '"Zagonel V"'

Search Results

1. How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study

2. The waiting time for prostate cancer treatment in Italy: analysis from the PROS-IT CNR Study

3. Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR)

4. Impact of Gastrointestinal Side Effects on Patients’ Reported Quality of Life Trajectories after Radiotherapy for Prostate Cancer: Data from the Prospective, Observational Pros-IT CNR Study

5. Prevalence of malnutrition in patients at first medical oncology visit: The PreMiO study

6. Quality of Life After Prostate Cancer Diagnosis: Data from the Pros-IT CNR

7. Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial

8. Will Molecular Biology Contribute to Refine Prognosis and to Select Treatment?

9. Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: A randomized, placebo- controlled, double-blind, multicenter trial

10. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial

11. Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

12. Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial

13. Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study

14. Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes

15. Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)

16. Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study

17. Early integration of palliative care in oncology practice: Results of the Italian Association of Medical Oncology (AIOM) survey

18. Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study

19. Sequential Treatment of Sorafenib–Regorafenib Versus Sorafenib–Physician’s Choice: A Propensity Score-Matched Analysis

20. Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

21. Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma

22. Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system

23. Second medical opinion in oncological setting

24. Clinical Management of Diffuse Low-Grade Gliomas

25. From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy

26. Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib

27. Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol

28. Nutritional support for cancer patients: still a neglected right?

29. Pros-IT CNR: an Italian prostate cancer monitoring project

30. Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes

31. The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials

32. Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: A detailed clinical, pathologic, and molecular characterization

33. Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma

34. Positon paper of the Italian Associaton of Medical Oncology on early palliatve care in oncology practce (Simultaneous Care)

35. Erratum to 'Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life' [Eur J Cancer 69 (2016) 110-118]

36. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): A proof-of-concept, multicentre, open-label, phase 2 trial

37. Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life

38. Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial

39. Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings

40. A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial

41. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer

42. Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer

43. Breakthrough pain in oncology: A longitudinal study

44. A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group

45. Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma

46. EXPRESSION OF MYELOID ASSOCIATED ANTIGENS IN CHRONIC LYMPHOCYTIC LEUKAEMIA

47. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1

48. Pharmacological modulation of peptide growth factor receptor expression on tumor cells as a basis for cancer therapy

49. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders

50. Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer

Catalog

Books, media, physical & digital resources